IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.

Benzer Materyaller

• IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
  Yazar:: Schwenk, Robert, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint
  Yazar:: Porter, Michael D., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
  Yazar:: Khan, Farhat, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
  Yazar:: Livingstone, Merricka C., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.
  Yazar:: Nathan Beutler, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-03-01)